3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma
7
Leiomyosarcoma
3
Sarcoma, Synovial
2
Sarcoma, Alveolar Soft Part
2
Ovarian Neoplasms
2
Neurofibrosarcoma
2
Malignant mesenchymal tumor
2
Liposarcoma
2
Histiocytoma, Malignant Fibrous
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Fibrosarcoma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Solitary Fibrous Tumors
1
Soft Tissue Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Endometrial Stromal
1
Rhabdomyosarcoma
1
Recurrent High Grade Meningioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Ichthyosis, X-Linked
1
Gastrointestinal Stromal Tumors
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Extraskeletal Myxoid
1
Central Nervous System Neoplasms
1
Interventions
Radiotherapy
9
Radiosurgery
6
Oxaliplatin
5
Cisplatin
5
Paclitaxel
4
Capecitabine
4
Leucovorin
3
Irinotecan
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
strontium chloride
2
regorafenib
2
pembrolizumab
2
enzalutamide
2
Zoledronic Acid
2
Temozolomide
2
Radiofrequency Ablation
2
Mitomycin
2
Methods
2
Ifosfamide
2
Gemcitabine
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Bleomycin
2
Bevacizumab
2
Analgesia
2
Albumin-Bound Paclitaxel
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Neoplasm Metastasis
×
Trabectedin
×
Clear all
NCT02066675
2018-04-11
TR1US
Italian Sarcoma Group
Phase 2
Completed
24 enrolled